ZUM-15434-90968
3 vaccinations
2 coded responses
12 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 535 / WI
- Registered
- 2021-11-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-11-05
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-06
Registered in v-safe
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-07
-
2021-11-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
-
2021-12-03
Survey response — day 28, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Report sent to call center — day 28, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-06
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-10
- 2021-12-17
-
2022-02-04
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Second pregnancy, second miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-08
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | No |
| 2 | 2021-04-19 | Pfizer-BioNTech | No |
| 3 | 2021-11-05 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-03 | Successful 2021-12-06 |
Participant prefers to complete VAERS report online |
| 2022-02-04 | Successful 2022-02-08 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — day 28, dose 3
Symptoms: Miscarriage
Release 11 — 3 months, dose 3
Symptoms: Second pregnancy, second miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release